MASON, Ohio, April 10, 2025--(BUSINESS WIRE)--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Shares of AtriCure, Inc. (NASDAQ:ATRC) hopped 0.22% to close at $26.82 yesterday, subsequent to the company's receipt of the FDA’s 510(k) clearance for additional C claims of its well-acclaimed ...
MASON, Ohio., AtriCure, Inc., a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage management (LAAM), today announced that it has launched the AtriClip FLEX•V™ ...
AtriCure, Inc. ATRC recently announced the treatment of the first patient with the AtriClip FLEX-Mini device. The device recently received the FDA 510(k) clearance. The AtriClip FLEX-Mini, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results